MX2024007632A - Una composicion farmaceutica para el tratamiento de infecciones oticas. - Google Patents

Una composicion farmaceutica para el tratamiento de infecciones oticas.

Info

Publication number
MX2024007632A
MX2024007632A MX2024007632A MX2024007632A MX2024007632A MX 2024007632 A MX2024007632 A MX 2024007632A MX 2024007632 A MX2024007632 A MX 2024007632A MX 2024007632 A MX2024007632 A MX 2024007632A MX 2024007632 A MX2024007632 A MX 2024007632A
Authority
MX
Mexico
Prior art keywords
treatment
pharmaceutical composition
otic infections
infections
otic
Prior art date
Application number
MX2024007632A
Other languages
English (en)
Spanish (es)
Inventor
Keith Freehauf
Sharon Cruz Martin
Allan Weingarten
Julien Thiry
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2024007632A publication Critical patent/MX2024007632A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MX2024007632A 2021-12-20 2022-12-19 Una composicion farmaceutica para el tratamiento de infecciones oticas. MX2024007632A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163291673P 2021-12-20 2021-12-20
PCT/EP2022/086649 WO2023117900A1 (en) 2021-12-20 2022-12-19 A pharmaceutical composition for the treatment of otic infections

Publications (1)

Publication Number Publication Date
MX2024007632A true MX2024007632A (es) 2024-07-09

Family

ID=84942883

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024007632A MX2024007632A (es) 2021-12-20 2022-12-19 Una composicion farmaceutica para el tratamiento de infecciones oticas.

Country Status (9)

Country Link
US (1) US20250049827A1 (cg-RX-API-DMAC7.html)
EP (1) EP4452269B1 (cg-RX-API-DMAC7.html)
JP (1) JP2024547035A (cg-RX-API-DMAC7.html)
CN (1) CN118434420A (cg-RX-API-DMAC7.html)
AU (1) AU2022421489A1 (cg-RX-API-DMAC7.html)
CA (1) CA3239989A1 (cg-RX-API-DMAC7.html)
ES (1) ES3050117T3 (cg-RX-API-DMAC7.html)
MX (1) MX2024007632A (cg-RX-API-DMAC7.html)
WO (1) WO2023117900A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021335500A1 (en) 2020-09-04 2023-05-04 Elanco Us Inc. Palatable formulations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2576589C (en) 2004-08-13 2013-11-12 Schering-Plough Ltd. Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid

Also Published As

Publication number Publication date
EP4452269B1 (en) 2025-09-03
EP4452269A1 (en) 2024-10-30
AU2022421489A1 (en) 2024-06-06
CA3239989A1 (en) 2023-06-29
WO2023117900A1 (en) 2023-06-29
CN118434420A (zh) 2024-08-02
US20250049827A1 (en) 2025-02-13
JP2024547035A (ja) 2024-12-26
ES3050117T3 (en) 2025-12-19

Similar Documents

Publication Publication Date Title
MX2024005716A (es) Composiciones farmaceuticas que comprenden meloxicam.
CO2018001407A2 (es) Composiciones con potenciadores de permeación para suministro de fármacos
CR20240363A (es) Compuestos y métodos para el tratamiento de infecciones virales.
CO2020008825A2 (es) Regímenes de dosificación superior de g1t38
MX2023006504A (es) Compuesto de hidroxamato, metodo de preparacion del mismo y aplicacion del mismo.
ECSP077239A (es) Formulación farmacéutica
MX2023002671A (es) Formulaciones agradables.
CL2021000924A1 (es) Uso de reboxetina para el tratamiento de narcolepsia
MX2021003830A (es) Uso terapéutico del glucagón y combinación que incluye el mismo.
CL2024001052A1 (es) Formulaciones y sistemas de erdafitinib para administración intravesical.
CL2020002544A1 (es) Inhibidor de ret para uso en tratar cáncer que tiene una alteración de ret
CL2019002218A1 (es) Formulaciones de combinación triple y métodos para tratar o reducir el riesgo de enfermedad cardiovascular.
MX2019015927A (es) Composiciones para administración de fármacos y métodos de uso de las mismas.
MX2017016774A (es) Agente terapeutico para la fibrosis.
AR115913A1 (es) Formas de dosificación oral biodisponibles, uso, métodos
MX2022002444A (es) Granulo recubierto, dispersion solida y preparacion que contiene hidrobromuro de vortioxetina enmascarante de sabor oral.
CO2021014253A2 (es) Formulación de tableta vaginal
AR126393A1 (es) Terapia combinada para el tratamiento de enfermedades hepáticas
CO2020001881A2 (es) Combinación farmacéutica sinérgica del enantiómero activo s-ketorolaco trometamina y clorhidrato de tramadol
MX2024007944A (es) Derivados de 4-fenil-tetrahidropiridina para el tratamiento de enfermedades auditivas.
LT3968956T (lt) Vietinė farmacinė mupirocino kompozicija, skirta bakterinių infekcijų ir žaizdų gydymui
UA120529U (uk) Спосіб збереження функції нирок у хворих, що страждають на подагру і метаболічний синдром
MX2022007065A (es) Parche de liberacion prolongada con amikacina para el tratamiento de infecciones cutaneas producidas por bacterias.
UY40059A (es) Una composición que comprende un principio activo y un ramnolípido
CO2024013497A1 (es) Combinación de celecoxib - acetaminofén de estabilidad mejorada y procedimiento para su preparación